Australian scientists will kickstart research into how early vaccine studies can safely support faster approvals of vaccines in response to infectious disease outbreaks.FEEVA (a Framework for Evidence Evaluation in Vaccine Assessment) ...

COVID and influenza are at peak circulation in winter, with several million people in Australia getting ill from these respiratory viruses each year.In a post-pandemic world, many Australians now think of influenza as the ...

Hepatitis C in Australia has decreased by 58% since 2015. More than 100,000 Australians have received curative hepatitis C treatments.There were 1,740 new hepatitis C infections in 2023. Only 8% of people living with ...

UNSW Sydney has received the largest single philanthropic donation in its history to work with regional partners to tackle one of the deadliest preventable cancers in the Pacific.    The $25.9 million donation from the Swire ...

Over the last decade, HIV diagnoses in Australia have continued to follow a downward trend, according to new data released today by the Kirby Institute at UNSW Sydney.While there were 722 new HIV diagnoses reported nationally in 2023 – ...

Australian workers living with long COVID cost the economy, on average, about $9.6 billion in 2022, according to a new study from The Kirby Institute at UNSW Sydney, The Australian National University (ANU) and the University of ...

Biomarkers for long COVID that were present in patients at eight months have largely resolved by 24 months among a cohort of people who contracted COVID-19 during Australia’s first wave. Jointly led by the Kirby Institute at UNSW ...

Almost 90 per cent of the 57 million people living with hepatitis C live in low- and middle-income countries, but only half of these countries currently provide curative treatments at an accessible cost, says a study by UNSW Sydney’s ...

Over the past 10 years, Australian diagnoses of gonorrhoea have doubled, while diagnoses of syphilis have tripled, according to a new report released today by the Kirby Institute at UNSW Sydney. Chlamydia is increasing too (up 12 ...

Australia has made great progress towards hepatitis C elimination, with an estimated 60 per cent of people living with hepatitis C having already been treated, but more work is needed if Australia is to eliminate hepatitis C as a ...

Women in Vanuatu will have access to lifesaving cervical cancer screening, vaccination and treatment, thanks to a transformational program launched yesterday in Port Vila that is being rolled out across the archipelago nation. The

The Kirby Institute at UNSW Sydney will receive $2.5 million over 5 years for the establishment of a new centre for Stronger Investments for Infectious Diseases (STRIDE), an innovative centre that will use innovative health economics ...

Despite disruptions to testing and risk behaviour during COVID-19, the latest data release from UNSW Sydney’s Kirby Institute shows Australia is tracking well towards the elimination of HIV transmission. HIV diagnoses in Australia ...

A multi-disciplinary team of researchers from the Kirby Institute at UNSW Sydney and the Doherty Institute have been announced as finalists in the prestigious 2023 Eureka Prize Awards Kirby Institute researchers Professor Miles ...

A new study from the Kirby Institute published today in Lancet Global Health has found that administering drugs for intestinal worm infections, scabies and impetigo to an entire population is an effective way to control these neglected ...

Increasing treatment access and reducing undiagnosed infections is vital for combatting HIV, a world first study co-led by the Kirby and Burnet Institutes finds. A ten-year study into the impact of HIV ‘treatment as prevention’ has ...

A landmark initiative to eliminate cervical cancer in the Western Pacific officially launched in Papua New Guinea. Thousands of women in Papua New Guinea’s Western Highlands Province are the first to benefit from an initiative to ...

The funding, awarded though the Medical Research Future Fund, will support innovative infectious disease research including the development of RNA vaccines and treatments, clinical trials, and enhanced strategies for hepatitis C and ...